Phase 3 Moderate-to-severe Atopic Dermatitis Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd201 enrolled2 locationsNCT07309055
Recruiting
Phase 3
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Moderate-to-severe Atopic Dermatitis
medac GmbH277 enrolled30 locationsNCT06239311
Recruiting
Phase 3
Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Moderate-to-severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD480 enrolled1 locationNCT06723080